Clinical Trials Browser

Phase 1 × Trastuzumab × Other hematologic neoplasm × Clear all

NCT01351350 2019-08-08

Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

Phase 1 Completed

68 enrolled 29 charts

Other hematologic neoplasm

Hematologic Neoplasms